Faulding's Safe-Connect valve cleared by FDA:
This article was originally published in Clinica
Faulding's Safe-Connect valve, an intravenous delivery system, has been cleared by the FDA for marketing in the US. Safe- Connect is injected percutaneously and allows a syringe or any other intravenous device to be attached. Fluid can flow in both directions, but a valve prevents back-flow upon device removal. Faulding, based in Elizabeth, New Jersey, estimates the world intravenous delivery market to be worth $25-40 million annually.